Diagnostic and pathogenic significance of glutamate receptor autoantibodies

Archives of Neurology

Volumn 65, Issue 5, 2008, Pages 589-592

  Pleasure, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 3; GLUTAMATE RECEPTOR 3 AUTOANTIBODY; GLUTAMATE RECEPTOR AUTOANTIBODY; GLUTAMIC ACID; IGG AUTOANTIBODY; INOSITOL PHOSPHATE;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ATAXIA; BRAIN DISEASE; BRAIN INFARCTION; BRAIN ISCHEMIA; DISEASE ASSOCIATION; DISEASE SEVERITY; ENCEPHALITIS; FOCAL EPILEPSY; HIGH RISK POPULATION; HODGKIN DISEASE; HUMAN; NONHUMAN; OLIVOPONTOCEREBELLAR ATROPHY; PARANEOPLASTIC SYNDROME; PASSIVE IMMUNIZATION; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RASMUSSEN SYNDROME; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSIENT ISCHEMIC ATTACK;

AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BIOLOGICAL MARKERS; BRAIN; BRAIN DISEASES; BRAIN ISCHEMIA; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; RECEPTORS, GLUTAMATE;

EID: 43549126023     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.5.589     Document Type: Review

References (33)

1. Vincent A, Lang B, Kleopa KA. Autoimmune channelopathies and related neurological disorders. Neuron. 2006;52(1):123-138.
2. Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science. 1994;265(5172):648- 651.
3. Wiendl H, Bien CG, Bernaconi P, et al. GluR3 antibodies: prevalence in focal epilepsy, but no specificity for Rasmussen's encephalitis. Neurology. 2001;57(8):1511-1514.
4. Mantegazza R, Bernasconi P, Baggi F, et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol. 2002;131(1-2):179-185.
5. Watson R, Jiang Y, Bermudez I, et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen's encephalitis. Neurology. 2004;63(1):43-50.
6. Ganor Y, Goldberg-Stern H, Lerman-Sagie T, et al. Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA. Epilepsy Res. 2005;65(1-2):11-22.
7. 2-subunit detected in a subgroup of patients with reversible autoimmune limbic encephalitis. Eur Neurol. 2007;58(3):152-158.
8. Takahashi Y, Mori H, Mishina M, et al. Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua. Neurology. 2003;61(7):891-896.
9. Mochizuki Y, Mizutani T, Isozaki E, et al. Acute limbic encephalitis: a new entity? Neurosci Lett. 2006;394(1):5-8.
10. DeGiorgio LA, Knostantinov KN, Lee SC, et al. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 2001;7(11):1189-1193.
11. Husebye ES, Sthoeger ZM, Dayan M, et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis. 2005;64(8):1210-1213.
12. Yoshio T, Onda K, Nara H, Minota S. Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2006;54(2):675-681.
13. Emmer BJ, van der Grond J, Steup-Beekman GM, Huizinga TW, van Buchem MA. Selective involvement of the amygdala in systemic lupus erythematosus. PLoS Med. 2006;3(12):e499. doi:10.1371/journal.pmed.0030499.
14. Kowal C, DeGiorgio LA, Lee JY, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A. 2006;103(52):19854-19859.
15. Lapteva L, Nowak M, Yarboro CH, et al. Anti-N-methyl-D- aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum. 2006;54(8):2505-2514.
16. Steup-Beekman G, Steens S, van Buchem M, Huizinga T. Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives. Lupus. 2007;16(5):329-334.
17. Dambinova SA, Khounteev GA, Izykenova GA, et al. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem. 2003;49(10):1752-1762.
18. Bokesch PM, Izykenova GA, Justice JB, et al. NMDA receptor antibodies predict adverse neurological outcome after cardiac surgery in high-risk patients. Stroke. 2006;37(6):1432-1436.
19. Carlson NG, Gahring LC, Rogers SW. Identification of the amino acids on a neuronal glutamate receptor recognized by an autoantibody from a patient with paraneoplastic syndrome. J Neurosci Res. 2001;63(6):480-485.
20. Coesmans M, Sillevis Smitt PA, Linden DJ, et al. Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies. Ann Neurol. 2003;53(3):325-336.
21. Sillevis Smitt P, Kinoshita A, De Leeuw B, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342(1):21-27.
22. Dalmau J, Tüzün E, Wu H-Y, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25-36.
23. Ganor Y, Teichberg VI, Levite M. TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage. J Immunol. 2007;178(2):683-692.
24. Koustova E, Sei Y, Fossom L, et al. LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor. J Clin Invest. 2001;107(6):737-744.
25. Rai G, Ray S, Shaw RE, et al. Models of systemic lupus erythematosus: development of autoimmunity following peptide immunizations of noninbred pedigreed rabbits. J Immunol. 2006;176(1):660-667.
26. Huerta PT, Kowal C, DeGiorgio LA, et al. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A. 2006;103(3):678-683.
27. Cohen-Kashi Malina K, Ganor Y, Levite M, Teichberg VI. Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels. Neurochem Res. 2006;31(10):1181-1190.
28. He X-P, Patel M, Whitney KD, et al. Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron. 1998;20(1):153-163.
29. Levite M, Fleidervish IA, Schwarz A, et al. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel. J Autoimmun. 1999;13(1):61-72.
30. Ganor Y, Gottlieb M, Eilam R, et al. Immunization with the glutamate receptor-derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures. Exp Neurol. 2005;195(1):92-102.
31. During MJ, Symes CW, Lawlor PA, et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science. 2000;287(5457):1453-1460.
32. Bien CG, Granata T, Antozzi C, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain. 2005;128(pt 3):454-471.
33. Gahring LC, Rogers SW, Twyman RE. Autoantibodies to glutamate receptor subunit GluR2 in nonfamilial olivopontocerebellar degeneration. Neurology. 1997;48(2):494-500.